SCHEMBL2278600

SCHEMBL2278600

CC(C)(Oc1ccc(Cl)cc1Sc1cccc(S(C)(=O)=O)c1Cl)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 11/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPT P10636 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGDR2 Q9Y5Y4 3/20 0.41
PPARG P37231 5/20 0.39
FABP2 P12104 1/20 0.39
SLC22A12 Q96S37 1/20 0.39
ACLY P53396 1/20 0.38
PPARD Q03181 7/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CCR2 P41597 1/20 0.34
USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1333682 0.80 PTGDR2 (0.46) PPARAMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL1333478 0.80 PTGDR2 (0.45) PPARAMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL1331579 0.73 PTGDR2 (0.52) MAPTPTGDR2
SCHEMBL1333694 0.70 PTGDR2 (0.40) PPARAPTGDR2PPARGACLYPPARD
SCHEMBL581884 0.69 PPARA (0.59) PPARAMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL1044677 0.69 KDM4E (0.57) PPARAMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL4628142 0.69 PPARA (0.54) PPARAMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL1331593 0.68 PPARA (0.57) PPARAMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL7978183 0.68 PPARA (0.57) PPARAMEN1CYP1A2CYP3A4CYP2D6
SCHEMBL1369354 0.67 PPARA (0.56) PPARAMEN1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003703-B2 Phenoxiacetic acid derivatives ASTRAZENECA AB (SE) 2011-08-23 US disclosed
US-20060293352-A1 Phenoxiacetic acid derivatives ASTRAZENECA AB (SE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293352-A1 Phenoxiacetic acid derivatives HRH2, HRH1, HCAR2 PPARA 430/4885MEN1 3996/4885CYP1A2 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.